mifepristone has been researched along with Chromosome Deletion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christin-Maitre, S; Guiochon-Mantel, A; Lescop, P; Loosfelt, H; Milgrom, E; Perrot-Applanat, M | 1 |
| Baulieu, EE; Cadepond, F; Jibard, N; Schweizer-Groyer, G; Segard-Maurel, I | 1 |
| Bélanger, L; Bocquel, MT; Chambon, P; Meyer, ME; Turcotte, B | 1 |
| Bocquel, MT; Chambon, P; Gronemeyer, H; Ji, JW; Meyer, ME; Pornon, A | 1 |
4 other study(ies) available for mifepristone and Chromosome Deletion
| Article | Year |
|---|---|
Mechanisms of nuclear localization of the progesterone receptor.
Topics: Animals; Antigens, Polyomavirus Transforming; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Chromosome Deletion; Cytoplasm; DNA; Macromolecular Substances; Mifepristone; Protein Processing, Post-Translational; Protein Sorting Signals; Rabbits; Receptors, Progesterone; Transfection | 1992 |
Mutations in the "zinc fingers" or in the N-terminal region of the DNA binding domain of the human glucocorticosteroid receptor facilitate its salt-induced transformation, but do not modify hormone binding.
Topics: Animals; Binding Sites; Cell Line; Chromosome Deletion; Cytosol; DNA-Binding Proteins; Humans; Kinetics; Mifepristone; Mutagenesis, Insertional; Osmolar Concentration; Plasmids; Potassium Chloride; Receptors, Glucocorticoid; Transfection; Triamcinolone Acetonide; Zinc Fingers | 1992 |
Repression of the alpha-fetoprotein gene promoter by progesterone and chimeric receptors in the presence of hormones and antihormones.
Topics: alpha-Fetoproteins; Animals; Base Sequence; Cell Line; Chickens; Chimera; Chromosome Deletion; Genes; Humans; Mifepristone; Molecular Sequence Data; Mutation; Oligonucleotide Probes; Progesterone; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Restriction Mapping; Tamoxifen; Transfection | 1990 |
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Topics: Animals; Binding Sites; Breast Neoplasms; Cell Line; Chickens; Chromosome Deletion; Female; Gene Expression Regulation; HeLa Cells; Humans; Mifepristone; Mutagenesis, Site-Directed; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Transcription, Genetic; Transfection | 1990 |